Award
Colorado Division of Veterans Affairs 5I01BX005651-03
Establishing the Therapeutic Efficacy of Alpha-1-Antitrypsin and Enoxaparin Against COVID-19
Recipient
VA EASTERN COLORADO HEALTH CARE SYSTEM
Awarded
August 06, 2026
Identifier
5I01BX005651-03
Research project to evaluate combination therapy of alpha-1-antitrypsin and enoxaparin for treating severe COVID-19, supporting development of effective therapies.
Description
This project aims to test the therapeutic efficacy of alpha-1-antitrypsin (AAT) combined with enoxaparin against SARS-CoV-2 infection and its consequences using in vitro and in vivo models.